Initial results from trials in 12- to 15-year-olds in the US will be handed to regulators.
ADVERTISEMENT
ADVERTISEMENT
This post is from BBC News. To read the rest of the story please head to the following link: https://www.bbc.co.uk/news/health-56591429.